TRVI

13.4352.08%
FS

Farrell Simon

Chief Commercial Officer

Dr. Farrell Simon, PharmD, is Director of Serina Therapeutics, Inc. from July 22, 2026. Mr. Simon is Chief Commercial Officer of Trevi Therapeutics, Inc. from February 2023. He was Senior Vice President and Head of Commercial & Strategy of Trevi Therapeutics, Inc. from February 2022 to February 2023 also and Vice President, Head of US Marketing, from September 2020 to February 2022. He is an experienced general manager who has successfully led operating plans for brands of varying sizes, geographies and has worked across the lifecycle of development from in-line brands to early commercial development assets. Prior to joining Trevi, he worked at Pfizer in commercial and operations roles. He last served as Chief of Staff to the Group President of Biopharma at Pfizer and was a member of the Biopharma executive leadership team from January 2018 to September 2020. This leadership team managed the medicines and vaccines within these business units addressed patient needs in cancer, rare disease, inflammation & immunology, primary care, infectious diseases and preventative care with vaccines. Prior to Pfizer, he gained general management, marketing and medical affairs experience at Procter & Gamble. He has previously sat on the advisory board for the Business School and the College of Pharmacy at the University of Florida. He founded and continues to lead, The Simon Cancer Foundation, a not-for-profit raising money for cancer patients attending college and its Chief Executive Officer. Dr. Simon is on the board of directors for the Greater New Haven Chamber of Commerce. He holds both an M.B.A. and a Pharm.D. from the University of Florida.

Positions